SCHEMBL16124484

SCHEMBL16124484

CC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 12/20 0.77
THRA P10827 9/20 0.77
PCNA P12004 8/20 0.77
LMNA P02545 4/20 0.77
POLB P06746 3/20 0.77
HIF1A Q16665 3/20 0.77
PPARG P37231 3/20 0.77
ABCB11 O95342 2/20 0.77
GABRA1 P14867 2/20 0.77
GABRA2 P47869 2/20 0.77
GABRB2 P47870 2/20 0.77
HPGD P15428 2/20 0.77
SMN1; SMN2 Q16637 2/20 0.77
HSD17B10 Q99714 2/20 0.77
RXRA P19793 2/20 0.77
CYP1A2 P05177 1/20 0.77
PGR P06401 1/20 0.77
CHRM2 P08172 1/20 0.77
HTR1A P08908 1/20 0.77
ADRA2A P08913 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tiratricol SCHEMBL30161572 0.87 THRB (1.00) THRBTHRAPCNALMNAPOLB
Tiratricol SCHEMBL743426 0.87 THRB (1.00) THRBTHRAPCNALMNAPOLB
Tiratricol SCHEMBL25149 0.87 THRB (1.00) THRBTHRAPCNALMNAPOLB
SCHEMBL14485277 0.86 THRB (0.77) THRBTHRAPCNALMNAPOLB
Tiratricol SCHEMBL1652870 0.86 THRB (0.77) THRBTHRAPCNALMNAPOLB
Tiratricol SCHEMBL8660328 0.86 THRB (0.97) THRBTHRAPCNALMNAPOLB
Tiratricol SCHEMBL10701956 0.86 THRB (0.97) THRBTHRAPCNALMNAPOLB
Tiratricol SCHEMBL2671904 0.86 THRB (0.97) THRBTHRAPCNALMNAPOLB
SCHEMBL13949709 0.85 THRB (0.77) THRBTHRAPCNALMNAPOLB
SCHEMBL16124436 0.85 PCNA (1.00) THRBTHRAPCNALMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2014-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY MKI67, PCNA, PCLAF THRB 2853/4885THRA 3069/4885PCNA 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.